WallStreetZenWallStreetZen

NYSE: STVN
Stevanato Group Spa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for STVN

Based on 7 analysts offering 12 month price targets for Stevanato Group Spa.
Min Forecast
$29.00+4.24%
Avg Forecast
$33.57+20.67%
Max Forecast
$37.00+33%

Should I buy or sell STVN stock?

Based on 7 analysts offering ratings for Stevanato Group Spa.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
1 analysts 14.29%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STVN stock forecasts and price targets.

STVN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-01
lockedlocked$00.00+00.00%2023-11-01
lockedlocked$00.00+00.00%2023-09-26
lockedlocked$00.00+00.00%2023-09-19
lockedlocked$00.00+00.00%2023-08-30
Wells Fargo
Bottom 21%
21
Strong BuyMaintains$35.00+25.81%2023-07-31
Bank of America
Top 9%
92
Strong BuyMaintains$35.00+25.81%2023-06-16Find out why

1 of 1

Forecast return on equity

Is STVN forecast to generate an efficient return?
Company
N/A
Industry
0.32%
Market
30.34%

Forecast return on assets

Is STVN forecast to generate an efficient return on assets?
Company
N/A
Industry
0.14%

STVN revenue forecast

What is STVN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$1.2B+3.41%
Avg 2 year Forecast
$1.3B+16.27%
Avg 3 year Forecast
$1.4B+25.95%
STVN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STVN earnings growth forecast

How is STVN forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
2.04%
Industry
30.72%
Market
17.9%
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
STVN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

STVN revenue growth forecast

How is STVN forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
8.57%
Industry
6.71%
Market
7.68%
STVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STVN vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
STVN$27.82$33.57+20.67%Strong Buy
ATR$127.32$152.00+19.38%Strong Buy
RGEN$159.27$188.75+18.51%Strong Buy
XRAY$31.88$37.00+16.06%Buy
TFX$231.08$250.00+8.19%Buy
View Top Medical Stocks

Stevanato Group Spa Stock Forecast FAQ

Is Stevanato Group Spa Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: STVN) stock is to Strong Buy STVN stock.

Out of 7 analysts, 4 (57.14%) are recommending STVN as a Strong Buy, 1 (14.29%) are recommending STVN as a Buy, 2 (28.57%) are recommending STVN as a Hold, 0 (0%) are recommending STVN as a Sell, and 0 (0%) are recommending STVN as a Strong Sell.

If you're new to stock investing, here's how to buy Stevanato Group Spa stock.

What is STVN's revenue growth forecast for 2023-2025?

(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 8.57% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Stevanato Group Spa's revenue in 2023 is $1,112,434,736.On average, 4 Wall Street analysts forecast STVN's revenue for 2023 to be $343,591,890,453, with the lowest STVN revenue forecast at $338,023,916,175, and the highest STVN revenue forecast at $357,966,957,804. On average, 4 Wall Street analysts forecast STVN's revenue for 2024 to be $386,339,392,340, with the lowest STVN revenue forecast at $372,545,947,780, and the highest STVN revenue forecast at $414,217,092,856.

In 2025, STVN is forecast to generate $418,475,824,775 in revenue, with the lowest revenue forecast at $413,620,101,983 and the highest revenue forecast at $423,375,878,572.

What is STVN's forecast return on assets (ROA) for 2023-2026?

(NYSE: STVN) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.14%.

What is STVN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year STVN price target, the average STVN price target is $33.57, with the highest STVN stock price forecast at $37.00 and the lowest STVN stock price forecast at $29.00.

On average, Wall Street analysts predict that Stevanato Group Spa's share price could reach $33.57 by Nov 1, 2024. The average Stevanato Group Spa stock price prediction forecasts a potential upside of 20.67% from the current STVN share price of $27.82.

What is STVN's forecast return on equity (ROE) for 2023-2026?

(NYSE: STVN) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.